Winner of the Wildfire Highly Cited Publication

Join us in celebrating the winners of the 2022 NSW Premier's Award for Wildfire Highly Cited Publication.

Winner of the Wildfire Highly Cited Publication

The Wildfire Highly Cited Publication Award is presented to an individual or research team for a highly cited publication that has a significant impact on the cancer field.

This year, the publication is: Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy (Cancer Cell, 2019 Feb 11; 35(2) 238–255).

Working together to improve outcomes for people with melanoma

The paper was co-authored with equal contributions from Dr Tuba Nur Gide, Dr Camelia Quek, Professor Richard Scolyer AO, Professor Georgina Long, and Dr James Wilmott – from Melanoma Institute Australia.

Originally published in 2019, the paper has now been cited more than 270 times, demonstrating its vital information for treatment selection and future therapeutic strategies for cancer patients. 

The results of the study showed how immunotherapy can be more effective for people with melanoma by comparing the response and resistance to single immunotherapy treatment (anti-PD01) and combined immunotherapy treatment (anti-PD1 and anti-CTLA-4).

The Cancer Institute NSW proudly supports Dr James Wilmott through a Translational Program Grant, and Doctors Tuba Nur Gide and Camelia Quek through Early Career Fellowships.

We congratulate this team of co-authors on their significant contribution to positively effecting the lives of people with cancer.

Professor Jacob George

More information about the award

The Wildfire Highly Cited Publication Award recognises a NSW researcher, or team of researchers, who has made a significant difference to cancer care or research practice and whose work will have a lasting impact on the cancer field.

This award will be given to an individual, or research team, for a highly cited publication published in a peer reviewed journal between 1 January 2019 –31 December 2019 that is expected to significantly influence cancer control or future research and align with the goals of the NSW Cancer Plan. Publications and citation rates will be identified using Dimensions Data, based on the 24 months after the first date of publication.

The successful award recipient(s) will receive a prize of $10,000 to assist their research endeavours, and a commemorative award.